3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Breast
1
Conditions
Prostatic Neoplasms
108
Carcinoma, Renal Cell
36
Melanoma
13
Kidney Neoplasms
13
Neoplasm Metastasis
11
Urinary Bladder Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Brain Neoplasms
9
Sarcoma
8
Lung Neoplasms
8
Prostate Cancer Metastatic
6
Neoplasms
5
Carcinoma, Transitional Cell
5
Adenocarcinoma
5
Prostate Adenocarcinoma
4
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Thyroid Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphatic Metastasis
2
Local Recurrence of Malignant Tumor of Prostate
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Interventions
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
radium Ra 223 dichloride
1
peposertib
1
fluoroazomycin arabinoside
1
cabozantinib
1
avelumab
1
Radiotherapy, Image-Guided
1
Radiation Dose Hypofractionation
1
PITX2 protein, human
1
Nomograms
1
Nivolumab
1
Metastasectomy
1
Leuprolide
1
Ipilimumab
1
Indocyanine Green
1
Goserelin
1
Docetaxel
1
DEAE-Dextran
1
CTLA-4 Antigen
1
Artificial Intelligence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Radiosurgery
×
Genitourinary
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts
NCT06546267
2025-06-11
PROST-ART
IRCCS San Raffaele
Recruiting
2,500 enrolled